Rapid treatment of “wearing off” in Parkinson’s disease
- 23 March 2004
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 62 (6_suppl_4), S27-S31
- https://doi.org/10.1212/wnl.62.6_suppl_4.s27
Abstract
Patients with advanced Parkinson’s disease (PD) may develop a variety of motor complications associated with levodopa therapy. Motor fluctuations, such as early morning akinesia and “wearing-off,” may respond to individualized medical management with titrated combinations of levodopa, dopamine agonists, COMT inhibitors and amantadine. Often with disease progression, dyskinesias and unpredictable, rapid “off” periods will also emerge. These motor complications are less amenable to traditional anti-parkinson therapy manipulation. This manuscript reviews approaches for “rescue” therapy in PD patients with “wearing off,” sudden “offs,” early morning akinesia, and variable response to individual doses of oral medications. Strategies for preparing and administering liquid levodopa are discussed within the context of gastric emptying, intestinal absorption, and active transport across the blood brain barrier. In addition other levodopa preparations in early development, including the orally administered levodopa methyl ester and the potential for a subcutaneously administered levodopa ethyl ester are reviewed. Furthermore, practical guidelines regarding the dosing, administration, use of the antiemetic trimethobenzamide (Tigan®), time to “on,” duration of benefit, and potential side effects associated with subcutaneously injected apomorphine are provided.Keywords
This publication has 25 references indexed in Scilit:
- Clinical Pharmacokinetic and Pharmacodynamic Properties of Drugs Used in the Treatment of Parkinson??s DiseaseClinical Pharmacokinetics, 2002
- The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's diseaseJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Transdermal Absorption of L-Dopa from a New System Composed of two Separate Layers of L-Dopa and Hydrogel in RatsDrug Development and Industrial Pharmacy, 2000
- Pharmacokinetic-Pharmacodynamic Relationships of Apomorphine in Patients with Parkinson??s DiseaseClinical Pharmacokinetics, 1999
- Physiological Roles of Integrin α6β1 in Ovarian FunctionsHormone Research in Paediatrics, 1998
- Golden Memories, Golden OpportunitiesNeurology, 1998
- Using Liquid Levodopa in the Treatment of Parkinson??s DiseaseDrugs & Aging, 1997
- Effect of Subcutaneous Administration of Levodopa Ethyl Ester, a Soluble Prodrug of Levodopa, on Dopamine Metabolism in Rodent Striatum: Implication for Treatment of Parkinson's DiseaseClinical Neuropharmacology, 1996
- AlgorithmNeurology, 1994
- Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopaMovement Disorders, 1994